NovaBay Pharmaceuticals


NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis
WWW novabay.com𝕏 novabaypharma

History

NovaBay Pharmaceuticals, Inc. was founded in 2000 by Ron Najafi to create a stable version of HOCl. Najafi, chemistry Nobel laureate Herbert C. Brown, and Purdue University Professor Dale Margerum recruited Dr. Lu Wang to become NovaBay's Director of Product Development. She developed the stable version of pure hypochlorous acid, without bleach impurities, which became NovaBay's first product, NeutroPhase.
NovaBay later launched additional products named CelleRx™ for Plastic Surgery and i-Lid™ Cleanser that was cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.